Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases

Published:2020-10-22 Issue:10 Volume:66 Page:3563-3569
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Yarur Andres J.^ORCID,Deepak Parakkal,Vande Casteele Niels,Battat Robert,Jain Anjali,Okada Lauren,Osterman Mark,Regueiro Miguel

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-020-06669-6.pdf

Reference14 articles.

1. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;22:699–710.

2. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for crohn’s disease. N Engl J Med. 2013;22:711–721.

3. Afif W, Loftus EV, Faubion WA, et al. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;9:1133–1139.

4. Yarur AJ, Jain A, Hauenstein SI, et al. Higher Adalimumab levels are associated with histologic and endoscopic remission in patients with Crohnʼs disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:409–415.

5. Ungar B, Levy I, Yavne Y, et al. Optimizing anti-TNF-α therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14:e2.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in IBD Research 2024: Pragmatic Clinical Research;Inflammatory Bowel Diseases;2024-05-01

2. Letter to the Editor: Switching from vedolizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study;Digestive and Liver Disease;2024-04

3. A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy;Journal of Clinical Medicine;2023-10-17

4. Systematic Literature Review and Meta-analysis: Real-World Mucosal Healing in Vedolizumab-Treated Patients with Crohn’s Disease;GastroHep;2022-02-16